Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox

• প্রধান লেখক: Jan Sus (লেখক), Jan Bosak (লেখক), Tomas Hauser (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Wiley, 2024-03-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Administration of oral medicinal products as crushed tablets or open capsules is an important delivery option for patients suffering from dysphagia. To obtain full interchangeability of generics with the original products, demonstration of bioequivalence (BE) between both products administe...